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PrescriptionsAbstract Interventions by the pharmacists have always been considered as a valuable input by the
health care community in the patient care process by reducing the medication errors, rationalizing
the therapy and reducing the cost of therapy. The primary objective of this study was to determine
the number and types of medication errors intervened by the dispensing pharmacists at OPD phar-
macy in the Khoula Hospital during 2009 retrospectively. The interventions ﬁled by the pharmacists
and assistant pharmacists in OPD pharmacy were collected. Then they were categorized and ana-
lyzed after a detailed review. The results show that 72.3% of the interventions were minor of which
40.5% were about change medication order. Comparatively more numbers of prescriptions were
intervened in female patients than male patients. 98.2% of the interventions were accepted by
the prescribers reﬂecting the awareness of the doctors about the importance of the pharmacy prac-
tice. In this study only 688 interventions were due to prescribing errors of which 40.5% interven-
tions were done in changing the medication order of clarifying the medicine. 14.9% of the
interventions were related to administrative issues, 8.7% of the interventions were related to selec-
tion of medications as well as errors due to ignorance of history of patients. 8.2% of the interven-
tions were to address the overdose of medications. Moderately signiﬁcant interventions were
observed in 19.4% and 7.5% of them were having the impact on major medication errors. Pharma-
cists have intervened 20.8% of the prescriptions to prevent complications, 25.1% were to rationalize
the treatment, 7.9% of them were to improve compliance. Based on the results we conclude that the
role of pharmacist in improving the health care system is vital. We recommend more number of
such research based studies to bring awareness among health care professionals, provide solution
102 H.A.M. Al Rahbi et al.to the prescription and dispensing problems, as it can also improve the documentation system,
emphasize the importance of it, reduce prescribing errors, and update the knowledge of pharmacists
and other health care professionals.
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The role of pharmacist has been diversiﬁed from dispensing med-
ications to patient care, patient counselor, health care educator,
and community service to clinical practice. The Joint Commission
on Accreditation of Healthcare Organizations (JCAHO) has rec-
ommended that all prescriptions must be reviewed by pharmacists
before dispensing and stressed that the outcomes should be docu-
mented as a result of direct patient care by the pharmacy (Liya
et al., 2003). Any error in ordering, transcribing, dispensing,
administering andmonitoring in theprocess ofmedication is called
medication error (Kim and Schepers, 2003). Intervention by the
pharmacist is warranted to detect these medication therapy prob-
lems, after which, solutions for these problems can be invented
or drug therapy optimized for each patient. These interventions
have developed by time and their forms, vary from the simplest
handwritten form to the computerized databases (Kim and Sche-
pers, 2003; US Food and Drug Administration, 2011). Further-
more, many of these problems can be prevented by educating
health care providers about them (Bieszk et al., 2002).
Health care professionals expecting the pharmacists and
pharmacies to have diversiﬁed responsibilities include monitor-
ing medication for people with acute and chronic disease, oper-
ating repeat prescription services, reviewing medication for
long-term users, prescribing under protocols, advising on the
management of common conditions and participating in local
and national health promotion or disease prevention activities
(Felicity, 2009). Documentation of their interventions is
important for justifying pharmacists’ services to the patient,
healthcare administrators and providers, patient care takers,
to strengthen the profession and the society in total (Felicity,
2009). These clinical interventions of pharmacists not only
have a positive impact on patient care but also decreased cost.
Recently, electronic systems and commercially available prod-
ucts and software packages are used for documentation of clin-
ical pharmacy interventions more efﬁciently than paper
systems. However, most out-patient pharmacies do not have
a central database for capturing interventions at experiential
locations (Majumdar and Soumerai, 2003; Fox, 2011).
A study done in USA, 2001 showed that the majority of the
prescriptions (76%) did not reach the patient, but had the po-
tential to cause morbidity or mortality signiﬁcantly, 22% were
duplicate orders, 19% were wrong doses, 16% were wrong fre-
quencies and other interventions contracted 19% (Kim and
Schepers, 2003). An Australian study carried out in a teaching
hospital indicates that 41.7% of the initial total interventions
were excluded as they were considered as minor to moderate
in signiﬁcance that would be likely to improve the therapeutic
outcome, without having a major impact upon the patient’s
health. The most common category of interventions was high
dose errors, that constitute for 43.6% of the severe interven-
tions (Alderman and Farmer, 2001). It has been proven that
the clinical interventions improve adherence to national clini-
cal practice guidelines and optimizing the pharmacy beneﬁtfor elderly. Interventions by the pharmacist in a psychiatric
hospital showed that 64.5% of the interventions were of no sig-
niﬁcance, 24.2% of minimal clinical signiﬁcance, 11.4% of
clinical signiﬁcance, and none was potentially life-threatening
(Bosma, 2007; Bieszk et al., 2002).
The documentation of interventions by the pharmacist at
the out-patient department of the Khoula Hospital has been
started from 2009 and during this time many interventions have
been made by the working pharmacists and assistant pharma-
cists. However, its impact on regular medical practice, patient
safety and improvement in patient care is not known. In
OPD, they still use the handwritten interventions, where phar-
macists have to send the prescription back to the doctor with
their comments in it, to clarify any unclear issues about the case
or medications. Sometimes, interventions are done by calling
the doctor. Importance of many pharmaceutical interventions
by the pharmacist in an OPD pharmacy is unnoticed or unre-
ported due to the lack of documentation. It was hypothesized
that, these interventions by the pharmacists were more signiﬁ-
cant in clinical practice and patient care in reducing drug asso-
ciated problems. Furthermore, we wanted to test if there is any
association between pharmaceutical intervention, on the one
hand, and prevention of complications, morbidity and
improvement of cost and compliance, on the other hand.
The main aim of the study was to know the prevalence of
different types of intervened medication errors, types of inter-
ventions, and action taken at OPD pharmacy in Khoula Hos-
pital Muscat, Oman during 2009.
2. Methodology
2.1. Study design
The present study is a systematic retrospective study carried
out by collecting the intervened prescriptions available at the
Out-patient pharmacy of Khoula Hospital Muscat. It was con-
ducted after an ofﬁcial permission obtained from the Director
General of Khoula Hospital. All prescriptions of 2009 inter-
vened by the pharmacist and ﬁlled in an OPD pharmacy were
collected and included in the study. Utmost care was taken to
include only those prescriptions which were intervened by the
pharmacists and documented well by their comment on the
prescription. The work experience of the staff, that used to
do the interventions independently, varies from as low as
2 years to more than 10 years. All prescriptions that were illeg-
ible or the intervention done by the pharmacist was not clearly
written, and any prescription that did not meet the inclusion
criteria was excluded. Conﬁdentiality of the information is
maintained by not disclosing patient name, patient ID, name
of the doctor who prescribed, and name of the pharmacist
who did the interventions. British National Formulary, Oman
National Formulary and Dipiro’s Pharmacotherapy are used
as standards to substantiate correct interventions by the
pharmacists.
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Pharmacists’ intervention and comments written on the pre-
scriptions were used to revise each error and classify it into
the following categories: (1) Change medication order/Clarify
medicine; (2) Medication selection recommendation; (3) Pre-
scribing medication without indication; (4) Therapeutic dupli-
cation; (5) Overdose; (6) Sub-therapeutic dose or duration; (7)
ADRs/drug–drug interaction; (8) Addition of another medi-
cine; (9) Transcription error; (10) Administrative issues; (11)
Not reviewing past medical history of pts.
2.3. Severity of consequences
Based on the seriousness of consequences caused by the inter-
vened medication errors the severity was categorized as minor
those that do not harm the patient and need monitoring; mod-
erate those that can cause a temporary harm if used; major
were those that can harm temporarily may be leading to hos-
pitalization, resulting in permanent harm, near-death or death
and others were those related to issues of administration and
pharmacoeconomics.
2.4. Reasons of interventions
The reasons for interventions written on the prescriptions were
read and categorized as to prevent complications and morbid-
ity, to rationalize the treatment, improve compliance and cost
and others.
2.5. Analysis of data
In a monthlywise statistic report, the data from the interventions
was recorded and then entered into an SPSS. After that, the data
was reviewed and evaluated. In the ﬁnal step, data was analyzed
and categorized. Based on pharmacists’ intervention, an effort
was made to identify the most common intervention, and other
factors. The data is presented in percent and numbers.
3. Results
The total number of prescriptions dispensed from the OPD
pharmacy at Khoula Hospital during the year 2009 wasFigure 1 Demography of intervened prescriptions.30,563. The number of interventions collected by the pharmacy
in the same year was 692 interventions which are about 2.3%
of the total dispensed. 688 interventions out of 692 were pre-
scribing errors. The results are described in the following
charts and tables:
3.1. Demography of intervened prescriptions
As shown in Fig. 1, 297 of the intervened prescriptions were of
male patients constituting 42.9% of the total and 381 were of
the female patients constituting 55.1% of the total intervened
prescriptions. 2% of the prescriptions were of infants having
14 in numbers.
3.2. Types of interventions at OPD pharmacy
In this study only 688 interventions were due to prescribing er-
rors of which 40.5% interventions were done in changing the
medication order of clarifying the medicine. 14.9% of the
interventions were related to administrative issues, 8.7% of
the interventions were related to selection of medications as
well as errors due to ignorance of history of patients. 8.2%
of the interventions were to address the overdose of medica-
tions. Transcription errors were intervened in 7.9% of the pre-
scriptions (Fig. 2).
3.3. Intervened medication errors of other category
Fig. 3 shows that there were some interventions done by the
pharmacist due to some other reasons. 23 of them were related
to patient non-compliance causing 3.3% and 10.1% of the
interventions were related to availability of the drug.
3.4. Percent of interventions accepted/rejected by prescribers
As shown in Table 1, 98.2% of the interventions made by the
pharmacists were accepted by the prescribers and 1.7% of
them were not accepted citing the medical conditions and other
circumstances.
3.5. Severity of intervened medication errors
As depicted in Fig. 4, 72.3% of the interventions were carried
out mainly to address the minor signiﬁcant medication errors.
Moderately signiﬁcant interventions were observed in 19.4%
and 7.5% of them were having the impact on major medica-
tion errors.
3.6. Pharmacists’ interventions for risk management
Pharmacists have intervened 20.8% of the prescriptions to pre-
vent complications, 25.1% were to rationalize the treatment,
7.9% of them were to improve compliance, three of them were
to reduce the cost, one was to prevent morbidity and major
contribution was to clarify the medication or non-availability
of the medication (Fig. 5).
4. Discussion
Most of the clinical interventions recorded by the dispensing
pharmacists in an OPD pharmacy showed that the majority of
Figure 2 Types of interventions at OPD pharmacy.
Figure 3 Intervened medication errors of others category.
Table 1 Percent of interventions accepted/rejected by
prescribers.
Value Count Percent
1 Accepted 680 98.2
2 Rejected 12 1.7
Figure 5 Pharmacist’s interventions for risk management.
Figure 4 Severity of intervened medication errors.
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having no potential to cause morbidity or mortality signiﬁcantly
whereas, 19.4% interventions were moderately signiﬁcant and
7.5% were majorly signiﬁcant. These results are similar to the
study carried out in 2001 inUSA at a dispensing pharmacy (Liya
et al., 2003). However, these results support the outcome of study
conducted in an Australian teaching hospital where they found
41.7% of interventions were mild–moderate (Alderman and
Farmer, 2001). Also, the study that was done in UK in 2004
showed closer results (Stubbs et al., 2004). A Danish prospective
studyhas shown32% interventionswere clinical and68%admin-istrative by nature. In the study period, a total of 55,522 prescrip-
tions were ﬁlled out together with 3,069 dose-dispensing
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prescriptions (Anton et al., 2011). However, results of our study
contradicts the inpatient interventions by clinical pharmacists
at Sultan Qaboos University Hospital, Muscat where 33% of
interventions were recorded to be majorly signiﬁcant, 39%
of interventions were undertaken to improve efﬁcacy and 30%
of interventions were to reduce the toxicity (Al Zadjali, 2007).
It is hard to believe that 40.5% of interventions were to change
medication order or to clarify the reason for prescribing that med-
ication. It is a concern in pharmacy practice and needs to be ad-
dressed. 14.9% administrative issues, 8.7% selection of
medication and need of reviewing past medical history of patients
each, 8.2%overdose, 7.9%transcription errors andother interven-
tions contracted 11%. The total documented interventions were
2.3% of the total dispensed prescriptions in a year. In contrast,
in aUS study 92%of the interventions were to change medication
order, 11% need to review past medical history, 73% medication
selection recommendation, and other interventions were 5%. A
study in UK showed that 76.3% of the interventions were about
errors in the prescription writing (administrative issues), including
transcribing medication order, omission of prescriber’s signature,
incomplete prescription, etc. (Liya et al., 2003; Kim and Schepers,
2003; Alderman and Farmer, 2001. Stubbs et al., 2004). A study
carried out in an ambulatory neurologic clinic notiﬁed 29% to dis-
continue amedication, 24% to add amedication, 23% to change a
dose, 20% for therapeutic substitutions, and 4% for therapeutic
monitoring (Swain and Lindy, 2012).
In some cases pharmacists have intervened to reduce the cost
ofmedications to improve the patient compliance and affordabil-
ity. A similar, kind of effort was also observed in a recommenda-
tionpassed byCapitated senior drugbeneﬁt plan 2002.One of the
studies inUSA, concluded that the cost saving interventions with
cost avoidance potentials were not well documented by most
pharmacies (Kim and Schepers, 2003; Bieszk et al., 2002).
Interventions in prescriptions obtained by females were
55.1% when compared to males of 42.9% this can be explained
due to the fact that female patients are more interested to
know about drugs, their indications and any drug therapy
problems from pharmacists. Similar results were viewed in a
Dutch study where male’s interventions constitute 41%, but
the opposite was in Australia where a research revealed
78.9% male and 21.1% female interventions (Alderman and
Farmer, 2001; Bosma, 2007).
One of the most important things noticed by the dispensing
pharmacists was problem with medication compliance. In this
study it was observed that 3.3% of interventions were to im-
prove the compliance of patients and 10.1% of interventions
due to non-availability of medications. These results indicate
that the dispensing pharmacists at OPD pharmacy are inter-
acting with the patients and counseling them to improve med-
ication compliance and also making them to understand the
importance of compliance.
The pharmacists’ intervention improved the balance be-
tween necessity and concern beliefs about medication, and efﬁ-
ciently resolved practical barriers in medication taking thereby
improving medication adherence in non-adherent RA patients
(Zwikker et al., 2012).
One of the recent prospective study carried out to know the
impact of clinical pharmacists’ interventions concluded that the
impact of clinical pharmacist providing patient counseling had
a positive impact on medication adherence and quality of life
(Ramanath, 2012; US Food and Drug Administration, 2011).The best thing found in the study is that the interventions
undertaken by the pharmacists are well received and accepted
(98.2%) by the working physicians in the hospital symbolizing
that the health care system in theKhoulaHospital is patient cen-
tered. These results are better than the results of a Dutch re-
search, where 82% of the interventions were accepted by the
prescribers (Bosma, 2007) In one of the prospective study lasting
4 years, the frequency of Pharmacists’ interventions remained
constant throughout the study period, with 47% accepted,
19% refused and 34% not assessable. The most frequent DRP
concerned improper administration mode (26%), drug interac-
tions (21%) and overdosage (20%). These resulted in changing
in the method of administration (25%), dose adjustment (24%)
and drug discontinuation (23%)with 307 drugs being concerned
by at least one pharmacists’ intervention. Paracetamol was in-
volved in 26%of overdosage pharmacists’ interventions. Eryth-
romycin as a prokinetic agent, presented a recurrent risk of
potentially severe drug–drug interactions especially with other
QT interval-prolonging drugs. Following an educational semi-
nar targeting this problem, the rate of acceptation of pharma-
cists’ intervention concerning this drug related problem
increased (Charpiat et al., 2012).
How important these interventions can be realized from the
data obtained in the study; 25.1% of interventions were to
rationalize the treatments, 20.8% of them were to prevent
complications, 7.9% of them were to improve patient compli-
ance and 45.5% of them were on clariﬁcation and drug non-
availability. In summary, we can say that 46% of interventions
have prevented morbidity, complications and rationalized the
therapy (Stubbs et al., 2004; Bosma, 2007). In one of the re-
cently conducted study it has been noted that the most com-
monly identiﬁed drug-related problems were drug
interactions (37%), overdosage (28%), non-conformity to
guidelines or contra-indications (23%), underdosage (10%)
and improper administration (2%). The clinical pharmacist’s
interventions consisted of dose adjustment (38%), addition
of drugs (31%), changes in drugs (29%) and optimization of
administration (2%) (Al-Hajje et al., 2012).
The Directors of Hospital Pharmacy recommended docu-
mentation of pharmacists’ interventions which can help in
enhancing the communication with other health care providers,
justifying workload, and identifying opportunities for focused
drug use review. Also, they pointed out that these interventions
reﬂect the wide range of services provided by pharmacy. A study
titled: Pharmacists’ intervention documentation in US health
care system, showed that 61% of the pharmacy directors re-
ported dissatisfaction with their documentation system, 14%
were neutral, and 25%were satisﬁed (Kim and Schepers, 2003).
Based on the outcome of the present study and recommen-
dations of previous studies we recommend to digitize the phar-
macists’ intervention documentation to allow maximum
ﬂexibility in data capture, analysis and reporting. This would
assist in providing customizable exporting/reporting features
focus on the sharing of intervention data within and outside
the pharmacy and health care services (Fox, 2011; King
et al., 2007). The newer electronic systems using handheld tech-
nology or web-based programs (Fox, 2011; MacKinnon,
2003), and other commercial intervention documentation tools
like Qunatiﬁ support easy documentation of pharmacists’
interventions in the health care setting. As shown these systems
would provide consistency and efﬁciency and a broad applica-
tion to an entire health care service; however, the outpatient
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MacKinnon, 2002). After implementation, we recommend
continued evaluation of the system and how it is used, as well
as longitudinal training for pharmacists working not only in
outpatient but also in other departments of the hospital
(Fox, 2011).
We also recommend further research to identify environ-
mental, organizational, ﬁnancial, socio-cultural, personal,
family or other contextual factors that may be pre-requisites
for the success of any interventions, and how the quality of
outpatient pharmacy services can be enhanced within a wider
reform framework.Acknowledgements
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